Treatment for glioblastoma (GBM)
Intended for US audiences only.
Optune® Novocure™

Calendar of events

February 17, 2018

Head for the Cure Foundation
Head for the Cure 5K
Charleston, SC

February 24, 2018

Head for the Cure Foundation
Head for the Cure 5K
Orlando, FL

February 26, 2018

Optune Open House
Santa Ana Orange County, CA
To RSVP, call: 1-855-281-9301

March 3, 2018

American Brain Tumor Association
BT5K
Dallas, TX

March 24, 2018

American Brain Tumor Association
BT5K
Tampa Bay, FL

March 25, 2018

Head for the Cure Foundation
Head for the Cure 5K
Central Texas, TX

April 14, 2018

Head for the Cure Foundation
Head for the Cure 5K
Columbus, OH

April 21, 2018

Head for the Cure Foundation
Head for the Cure 5K
Kansas City, MO

April 22, 2018

American Brain Tumor Association
BT5K
Chicago, IL

April 29, 2018

Head for the Cure Foundation
Head for the Cure 5K
Mid-MO, MO

May 5, 2018

American Brain Tumor Association
BT5K
Denver, CO

May 5, 2018

Head for the Cure Foundation
Head for the Cure 5K
North Texas, TX

May 12, 2018

American Brain Tumor Association
BT5K
Milford, MI

May 15, 2018

Head for the Cure Foundation
Head for the Cure 5K
New York, NY

May 20, 2018

Head for the Cure Foundation
Head for the Cure 5K
Des Moines, IA

June 2, 2018

American Brain Tumor Association
BT5K
Columbus, OH

June 16, 2018

Head for the Cure Foundation
Head for the Cure 5K
Wichita, KS

June 24, 2018

Head for the Cure Foundation
Head for the Cure 5K
St. Louis, MO

June 30, 2018

Head for the Cure Foundation
Head for the Cure 5K
Seattle, WA

July 22, 2018

Head for the Cure Foundation
Head for the Cure 5K
Omaha, NE

August 26, 2018

Head for the Cure Foundation
Head for the Cure 5K
Overland Park, KS

September 15, 2018

Head for the Cure Foundation
Head for the Cure 5K
Detroit, MI

September 22, 2018

Head for the Cure Foundation
Head for the Cure 5K
San Antonio, TX

October 6, 2018

Head for the Cure Foundation
Head for the Cure 5K
Cleveland, OH

October 13, 2018

Head for the Cure Foundation
Head for the Cure 5K
Houston, TX

October 13, 2018

American Brain Tumor Association
BT5K
Twin Cites, MN

Find a Treatment Center

OPT-041.6-34


CONTACT AN OPTUNE EXPERT

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure™, the maker of Optune.

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.


Please click here to see the Optune Instructions For Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals.


Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).